Safety profile of biological therapies for treating rheumatoid arthritis.

about

Tocilizumab: A Review in Rheumatoid Arthritis.Bimodal Function of Anti-TNF Treatment: Shall We Be Concerned about Anti-TNF Treatment in Patients with Rheumatoid Arthritis and Heart Failure?

P2860

Q43280791-CC9E7DF6-17B1-42DA-BD24-CF7B07AC445C Q55691195-50A93DB7-4459-45E0-A088-331485549A35

P2860

Safety profile of biological therapies for treating rheumatoid arthritis.

Item

http://www.wikidata.org/entity/Q38665700

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Safety profile of biological therapies for treating rheumatoid arthritis.

@en

type

Item

label

Safety profile of biological therapies for treating rheumatoid arthritis.

@en

prefLabel

Safety profile of biological therapies for treating rheumatoid arthritis.

@en

P1476

Safety profile of biological therapies for treating rheumatoid arthritis.

@en

P2093

Ma Victoria Hernández

http://www.w3.org/2001/XMLSchema#string

P2860

The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation

From C-Reactive Protein to Interleukin-6 to Interleukin-1: Moving Upstream To Identify Novel Targets for Atheroprotection

Consensus statement of the Spanish Society of Rheumatology on risk management of biologic therapy in rheumatic patients

Risk of tuberculosis in patients with chronic immune-mediated inflammatory diseases treated with biologics and tofacitinib: a systematic review and meta-analysis of randomized controlled trials and long-term extension studies

Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis.

Rituximab for Rheumatoid Arthritis.

Systematic review and meta-analysis of serious infections with tofacitinib and biologic disease-modifying antirheumatic drug treatment in rheumatoid arthritis clinical trials

Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent

Impact of anti-rheumatic treatment on immunogenicity of pandemic H1N1 influenza vaccine in patients with arthritis

Abatacept and reduced immune response to pandemic 2009 influenza A/H1N1 vaccination in patients with rheumatoid arthritis.

P304

1089-1103

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/14712598.2017.1346078

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Juan D Cañete

R Sanmarti

María Victoria Hernández

P577

2017-06-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28657381

http://www.w3.org/2001/XMLSchema#string

Safety profile of biological therapies for treating rheumatoid arthritis.

about

P2860

P2860

Safety profile of biological therapies for treating rheumatoid arthritis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698